Zhou, W.X. et al. 2026. Strong Signals of Adverse Events in Tyrosine Kinase Inhibitor Therapy for Liver Cancer Treatment. World Journal of Oncology. (Jan. 2026). DOI:https://doi.org/10.14740/wjon2685.